GL Biochem (Shanghai) Ltd

Firmenname:GL Biochem (Shanghai) Ltd
Telefon:21-61263452
E-Mail:ymbetter@glbiochem.com
Nationalität:China
URL: www.glschina.com/
Produkte insgesamt:9981

Produktkatalog

GP120-W61D-71;IRSDNFMDNTKTIIVC76H127N21O25S
GP120-W61D-72;NFMDNTKTIIVQLNEC77H126N20O26S
GP120-W61D-72-S;NFMDNTKTIIVC57H94N14O18S
GP120-W61D-73;NTKTIIVQLNESVAIC72H127N19O24
GP120-W61D-74;IIVQLNESVAINCTRC71H125N21O23S
GP120-W61D-74-S;LNESVAINCTRC49H86N16O18S
GP120-W61D-75;LNESVAINCTRPNNNC66H111N23O25S
GP120-W61D-76;VAINCTRPNNNTRKGC66H116N26O22S
GP120-W61D-77;CTRPNNNTRKGIHIGC68H117N27O21S
GP120-W61D-78;NNNTRKGIHIGPGRAC66H113N27O20
GP120-W61D-79;RKGIHIGPGRAFYAAC74H116N24O17
GP120-W61D-8;AAEQLWVTVYYGVPVC82H119N17O22
GP120-W61D-80;HIGPGRAFYAARKIIC78H124N24O17
GP120-W61D-81;GRAFYAARKIIGDIRC77H127N25O19
GP120-W61D-82;YAARKIIGDIRQAHCC74H123N25O20S
GP120-W61D-83;KIIGDIRQAHCNLSRC72H126N26O21S
GP120-W61D-84;DIRQAHCNLSRAQWNC75H118N28O23S
GP120-W61D-85;AHCNLSRAQWNNTLKC74H118N26O22S
GP120-W61D-86;LSRAQWNNTLKQIVIC80H134N24O22
GP120-W61D-87;QWNNTLKQIVIKLREC85H143N25O23
GP120-W61D-88;TLKQIVIKLREHFGNC82H138N24O21
GP120-W61D-89;IVIKLREHFGNKTIKC83H142N24O20
HIV-1 MN ENV-9;LWVTVYYGVPVWKEAC91H128N18O21
GP120-W61D-90;LREHFGNKTIKFNQSC81H127N25O23
HATPPKKKRK, 5-TMR labeled;5-TMR-HATPPKKKRKC82H119ClN22O18
HATPPKKKRK, Biotinylated;Biotin-HATPPKKKRKC63H109N21O14S
HATPPKKKRK;HATPPKKKRKC53H95N19O12
hBD-1, β-Defensin-1, human;DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK(Disulfidebridge:5-34,12-27,17-35)
hBD-3, β-Defensin-3, human;GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK(Disulfidebridge:11-40,18-33,23-41)
hBD-4, β-Defensin-4, human;ELDRICGYGTARCRKKCRSQEYRIGRCPNTYACCLRK(Disulfidebridge:6-33:13-27:17-34)
HBVpol455? HBV polymerase (455-463);GLSRYVARL
HCV (Hepatitis C Virus) NS3/4A Protease Substrate;Ac-DE-Dap(QXL520)-EE-Abu-ψ-[COO]AS-C(5-FAMsp)-NH2
HCV Core Protein (1-20)??;MSTNPKPQRKTKRNTNRRPQ
HCV NS3/4A Protease Substrate Hydrolysis Product 1;Ac-DE-Dap(QXL520)-EE-Abu
HCV NS3/4A Protease Substrate Hydrolysis Product 2;Lac-Ser-Cys(5-FAMsp)-NH2
HCV Protease Substrate (RET S1);Ac-DE-D(Edans)-EE-Abu-ψ-[COO]-AS-K(Dabcyl)-NH2
HCV, NS4A-Like Peptide??;KKGSVVIVGRIVLSGKPAIIPKK
H-D-Phe-Pro-Arg-AFC;fPR-AFCC30H34F3N7O5
H-D-Val-Leu-Arg-AFC;vLR-AFCC27H38F3N7O5
H-D-Val-Leu-Lys-AFC;vLK-AFC97055-77-1C27H38F3N5O5
Hemoglobin, 2837a, Malaria FRET substrate III??;DABCYL-GABA-Ala-Leu-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-EDANS
Hemoglobin, 3037a, Malaria FRET Substrate II??;DABCYL-GABA-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-EDANS
Hepatitis Virus C NS3 Protease Inhibitor 2;Ac-DE-Dif-E-Cha-CC43H56N6O14S
Hepatitis Virus C NS3 Protease Inhibitor 3;Ac-DE-Dif-I-Cha-CC44H60N6O12S
Hepatitis Virus C NS3 Protease Inhibitor 4;Ac-DELE-Cha-CC34H54N6O14S
HER2/Neu Substrate;AAEEIYAARRGC51H83N17O17
H-Glu-Ala-Ala-Phe-AFC;EAAF-AFCC30H32F3N5O8
H-Gly-Pro-AMC;GP-AMCC17H19N3O4
HIF-1 {alpha} (556-574)??;DLDLEMLAPYIPMDDDFQL1201633-99-9C101H152N20O34S2
HIF-2 (66-84)??;SLEAQGIKADRETVAVKPT
Growth Hormone Releasing Factor, GRF (1-44), amide, bovine;YADAIFTNSYRKVLGQLSARKLLQDIMNRQQGERNQEQGAKVRL-NH2
Growth Hormone Releasing Factor, GRF (1-44), amide, human;YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2
Growth Hormone Releasing Factor, GRF (1-44), amide, porcine;YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGERNQEQGARVRL-NH2
Growth Hormone Releasing Factor, GRF, (1-40), human;YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGA
GSK3 Substrate, a, b subunit;RAAVPPSPSLSRHSSPHQSEDEEEC108H169N35O42
GSK-3 Substrate, Biotinylated, Phosphorylated;Biotin-RRAAEELDSRAG-pS-PQLC86H143N29O29S
GSK-3 Substrate, Biotinylated;Biotin-RRAAEELDSRAGSPQLC81H136N28O28S
GST-Sa Chimera-Catalyzed Peptide;EAIYAAPFAKC52H77N11O14
Gycogen Synthase-derived peptide, phosphorylated, TAMRA-labeled??;5-TAMRA-KKLNRTL-pS-VA-OH
Gycogen Synthase-derived peptide, phosphorylated??;KKLNRTL-pS-VA-OH
H-Ala-Arg-Arg-AFC;ARR-AFCC25H35F3N10O5
H-Ala-Leu-Lys-AMC;ALK-AMCC25H37N5O5
H-Ala-Phe(4-fluoro)-Arg-Cha-homoArg-Tyr(3-iodo)-NH2;C43H65FIN13O7
H-Ala-Phe(4-fluoro)-Arg-Cha-homoArg-Tyr-NH2;C43H66FN13O7
HA-pT-PPKKKRK, Phosphorylated;HA-pT-PPKKKRKC53H96N19O15P
HATPPKKKRK, 5-FAM labeled;5-FAM-HATPPKKKRKC74H105N19O18
HIV Protease FRET Substrate I;DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS127134-13-8C73H97N17O18S
HIV Protein Reverse Transcriptase Peptide (RT33-41);ALVEICTEMC42H73N9O15S2
HIV-1 CONSENSUS B VIF-1;MENRWQVMIVWQVDRC88H136N26O23S2
HIV-1 CONSENSUS B VIF-10;GWFYRHHYESTHPRIC93H124N28O22
HIV-1 CONSENSUS B VIF-11;RHHYESTHPRISSEVC78H119N27O25
HIV-1 CONSENSUS B VIF-12;ESTHPRISSEVHIPLC74H120N22O24
HIV-1 CONSENSUS B VIF-13;PRISSEVHIPLGDAKC71H119N21O22
HIV-1 CONSENSUS B VIF-14;SEVHIPLGDAKLVITC72H122N18O22
HIV-1 CONSENSUS B VIF-15;IPLGDAKLVITTYWGC79H123N17O21
Histone deacetylase, HDAC substrate??;Ac-RGK(Ac)-AMC
Histone H1-derived peptide, FAM-labeled??;5-FAM-GGGPATPKKAKKL-OH
Histone H1-derived peptide, phosphorylated??;GGGPA-pT-PKKAKKL-OH
Histone H1-derived peptide, TAMRA labeled??;5-TAMRA-GGGPATPKKAKKL-OH
Histone H3 (1-21), Biotinylated??;ARTKQTARKSTGGKAPRKQLA-GG-K(BIOTIN)-NH2
Histone H3 (1-21), N-Terminal??;ARTKQTARKSTGGKAPRKQLA
HIV gag p24 peptide (197-205);
HIV-1 MN #1957;PKISFEPIPIHYCAPAGFAIC105H155N23O25S
HIV-1 MN #1990;SKLKEQFKNKTIVFNQSSGGC99H162N28O31
GP120-W61D-91;FGNKTIKFNQSSGGDC69H106N20O24
GP120-W61D-92;TIKFNQSSGGDPEIVC69H110N18O25
GP120-W61D-93;NQSSGGDPEIVRHSFC68H104N22O25
GP120-W61D-94;GGDPEIVRHSFNCGGC64H97N21O22S
GP120-W61D-95;EIVRHSFNCGGEFFYC83H113N21O23S
GP120-W61D-96;HSFNCGGEFFYCDTTC76H98N18O25S2
GP120-W61D-97;CGGEFFYCDTTQLFNC78H105N17O25S2
GP120-W61D-97-S;FFYCDTTQLFNC66H87N13O19S
GP120-W61D-98;FFYCDTTQLFNSTWNC88H115N19O26S
GP120-W61D-98-S;DTTQLFNSTWNC58H83N15O21
GP120-W61D-99;DTTQLFNSTWNGTEGC80H117N21O33
GPHRSTPESRAAV, 5-FAM labeled;5-FAM-GPHRSTPESRAAVC77H103N21O25
GPHRSTPESRAAV, 5-TMR labeled;5-TMR-GPHRSTPESRAAVC85H117ClN24O25
GPHRSTPESRAAV, Biotinylated;Biotin-GPHRSTPESRAAVC66H107N23O21S
GR231118;H-Ile-Glu-Pro-Dap-Tyr-Arg-Leu-Arg-Tyr-NH2158859-98-4C110H170N34O24
GRGDS, amide;GRGDS-NH2143648-02-6C17H31N9O8
Copyright 2019 © ChemicalBook. All rights reserved